Literature DB >> 23312599

Influence of early daptomycin therapy on treatment outcome of meticillin-resistant Staphylococcus aureus bacteraemia with high vancomycin minimum inhibitory concentrations.

Chun-Wen Cheng, Po-Chang Hsu, Chien-Chang Yang, Hong-Jyun Chang, Leung-Kei Siu, Tsu-Lan Wu, Ching-Tai Huang, Ming-Hsun Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23312599     DOI： 10.1016/j.ijantimicag.2012.10.019

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  6 in total

Review 1.  Clinical management of Staphylococcus aureus bacteremia: a review.

Authors:  Thomas L Holland; Christopher Arnold; Vance G Fowler
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

2.  Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry.

Authors:  Armando Gonzalez-Ruiz; Panayiotis Gargalianos-Kakolyris; Artur Timerman; Jayanta Sarma; Víctor José González Ramallo; Kamel Bouylout; Uwe Trostmann; Rashidkhan Pathan; Kamal Hamed
Journal:  Adv Ther       Date:  2015-06-25       Impact factor: 3.845

3.  A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.

Authors:  Shirin Kalimuddin; Yvonne F Z Chan; Rachel Phillips; Siew Pei Ong; Sophia Archuleta; David Chien Lye; Thuan Tong Tan; Jenny G H Low
Journal:  Trials       Date:  2018-06-01       Impact factor: 2.279

Review 4.  Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis.

Authors:  Masaru Samura; Yuki Kitahiro; Sho Tashiro; Hiromu Moriyama; Yuna Hamamura; Isamu Takahata; Rina Kawabe; Yuki Enoki; Kazuaki Taguchi; Yoshio Takesue; Kazuaki Matsumoto
Journal:  Pharmaceutics       Date:  2022-03-27       Impact factor: 6.321

5.  Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial.

Authors:  Shirin Kalimuddin; Rachel Phillips; Mihir Gandhi; Nurun Nisa de Souza; Jenny G H Low; Sophia Archuleta; David Lye; Thuan Tong Tan
Journal:  Trials       Date:  2014-06-19       Impact factor: 2.279

6.  Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience.

Authors:  R Andrew Seaton; Francesco Menichetti; Georgios Dalekos; Andres Beiras-Fernandez; Francisco Nacinovich; Rashidkhan Pathan; Kamal Hamed
Journal:  Adv Ther       Date:  2015-11-26       Impact factor: 3.845
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.